Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 4.88 USD -5.24% Market Closed
Market Cap: 751.2m USD

Intrinsic Value

The intrinsic value of one XERS stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.88 USD, Xeris Biopharma Holdings Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

XERS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Xeris Biopharma Holdings Inc

XERS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for XERS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XERS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Xeris Biopharma Holdings Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xeris Biopharma Holdings Inc

Current Assets 167.7m
Cash & Short-Term Investments 71.6m
Receivables 40.4m
Other Current Assets 55.6m
Non-Current Assets 155.4m
PP&E 28.2m
Intangibles 121.8m
Other Non-Current Assets 5.4m
Efficiency

Free Cash Flow Analysis
Xeris Biopharma Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Xeris Biopharma Holdings Inc

Revenue
203.1m USD
Cost of Revenue
-36.8m USD
Gross Profit
166.2m USD
Operating Expenses
-199.9m USD
Operating Income
-33.6m USD
Other Expenses
-21.2m USD
Net Income
-54.8m USD
Fundamental Scores

XERS Profitability Score
Profitability Due Diligence

Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROE
ROE is Increasing
hidden
Profitability
Score

Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

XERS Solvency Score
Solvency Due Diligence

Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XERS Price Targets Summary
Xeris Biopharma Holdings Inc

Wall Street analysts forecast XERS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XERS is 6.38 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
17% Downside
Average
Price Target
6.38 USD
31% Upside
Highest
Price Target
8.4 USD
72% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Xeris Biopharma Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XERS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

XERS Insider Trading
Buy and sell transactions by insiders

XERS News

What is the Intrinsic Value of one XERS stock?

The intrinsic value of one XERS stock under the Base Case scenario is hidden USD.

Is XERS stock undervalued or overvalued?

Compared to the current market price of 4.88 USD, Xeris Biopharma Holdings Inc is hidden .

Back to Top